![Foto de Felipe](/img/nophoto.png)
Felipe
Casanueva Freijó
Publications dans lesquelles il/elle collabore avec Felipe Casanueva Freijó (14)
2022
-
Epigenetic Effects of Healthy Foods and Lifestyle Habits from the Southern European Atlantic Diet Pattern: A Narrative Review
Advances in nutrition (Bethesda, Md.), Vol. 13, Núm. 5, pp. 1725-1747
-
Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21
Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917
2020
-
Hacia un score de la Dieta Atlántica
Bases científicas de la Dieta Atlántica (Servicio de Publicaciones e Intercambio Científico), pp. 265-271
2019
-
ANGPTL-4 is associated with obesity and lipid profile in children and adolescents
Nutrients, Vol. 11, Núm. 6
2018
-
Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty
Scientific Reports, Vol. 8, Núm. 1
-
Plasma ANGPTL-4 is Associated with Obesity and Glucose Tolerance: Cross-Sectional and Longitudinal Findings
Molecular Nutrition and Food Research, Vol. 62, Núm. 10
2017
-
Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway
World Journal of Gastroenterology, Vol. 23, Núm. 35, pp. 6403-6411
2016
-
FNDC5 is produced in the stomach and associated to body composition
Scientific Reports, Vol. 6
-
Regulation of Growth Hormone by the Splanchnic Area
Progress in Molecular Biology and Translational Science (Elsevier B.V.), pp. 41-60
-
Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner
European Journal of Nutrition, Vol. 55, Núm. 2, pp. 529-536
2015
-
Peripheral signals mediate the beneficial effects of gastric surgery in obesity
Gastroenterology Research and Practice, Vol. 2015
-
Regulation of NUCB2/nesfatin-1 production in rat's stomach and adipose tissue is dependent on age, testosterone levels and lactating status
Molecular and Cellular Endocrinology, Vol. 411, pp. 105-112
2014
-
Drug development strategies for the treatment of obesity: How to ensure efficacy, safety, and sustainable weight loss
Drug Design, Development and Therapy, Vol. 8, pp. 2391-2400
2013
-
The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake
PLoS ONE, Vol. 8, Núm. 11